Curran Simpson

Curran Simpson

Verkställande Direktör på REGENXBIO INC.

Förmögenhet: 3 M $ per 2026-08-31

64 år
Health Technology
Consumer Services
Process Industries

Profil

Curran M.
Simpson
currently works at REGENXBIO, Inc., as President, Chief Executive Officer & Director from 2024 and Alliance for Regenerative Medicine, as Director.
Mr. Simpson also formerly worked at Biogen MA, Inc., as Director-Manufacturing Sciences from 2001 to 2003, Covance Biotechnology Services, Inc., as Engineering Director from 1999 to 2001, Genentech, Inc., as Senior Research Engineer from 1992 to 1995, Nalco Chemical Co., as Senior Chemist from 1985 to 1987, Genencor International, Inc., as Senior Scientist-Development from 1987 to 1992, GSK Plc, as COO & Head-North American Supply Chain from 2012 to 2015, Novo-Nordisk Biochem, Inc., as Manager-Pilot Plant North America Division from 1995 to 1997, and Human Genome Sciences, Inc., as Senior Vice President-Operations from 2006 to 2012.
Mr. Simpson received his undergraduate degree from Clarkson College and graduate degree from Clarkson University.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-07-01 338 053 ( 0,51 % ) 3 M $ 2026-08-31

Aktiva positioner av Curran Simpson

FöretagPositionStart
REGENXBIO INC. Verkställande Direktör 2024-07-01
Direktör/Styrelseledamot -

Tidigare kända positioner av Curran Simpson

FöretagPositionSlut
GSK PLC Verksamhetschef 2015-08-01
Verksamhetschef 2012-12-01
Företagsledare/Principal 2003-01-01
Företagsledare/Principal 2001-01-01
Novo-Nordisk Biochem, Inc.
Företagsledare/Principal 1997-01-01
Se detaljerna i Curran Simpsons erfarenhet

Curran Simpsons utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

68

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Novo-Nordisk Biochem, Inc.

Health Services

  1. Börsen
  2. Insiders
  3. Curran Simpson
-40% : Prolongation exceptionnelle ➤➤➤➤
d
:
:
TA DEL AV DET NU